Tharimmune prices $55 million registered offering

Tharimmune Inc. (NASDAQ: THAR) announced the pricing of a $55 million registered offering on January 20, 2026. The company operates digital asset treasury strategies through participation in the Canton Network blockchain platform.

The offering includes 1.8 million shares of common stock priced at $2.92 per share and pre-funded warrants to purchase up to 17 million shares at $2.9199 per warrant. The transaction is expected to close on or about January 21, 2026, subject to customary closing conditions.

Clear Street serves as the sole bookrunner for the offering. The company stated the proceeds will fund continued expansion and development of its Canton-centric digital asset treasury strategy and provide working capital for general corporate purposes.

The securities are being offered under a shelf registration statement filed with the Securities and Exchange Commission on January 9, 2026, which became effective January 16, 2026. A prospectus supplement and accompanying prospectus were filed with the SEC on January 20, 2026.

Tharimmune describes itself as the first publicly traded company to leverage Canton Coin to support the Canton Network's digitization of financial markets. The company also operates clinical-stage biotech research and development activities.

You May Also Be Interested In

• DBV Technologies refreshes ATM program with $150M ADS offering
• Richard Lowenthal resigns from ARS Pharmaceuticals board
• Csquare prices IPO at $21 per share, raising $1.01 billion